Skip to content

A study to evaluate efficacy of sitz bath with unani anti inflammatory drugs in benign prostatic hyperplasia

THERAPEUTIC EFFECT OF ABZAN (SITZ BATH) WITH ADVIA MUHALLILAH (ANTI INFLAMMATORY DRUGS) IN THE MANAGEMENT OF AZM-E-GUDDA-E- MADHI (BENIGN PROSTATIC HYPERPLASIA) - BPH

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089985
Enrollment
40
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Sitz Bath with Advia Muhallilah (Anti Inflammatory Drugs): (1) Tukhm e shibt 10 gm (2) Tukhm e hulbah 10 gm (3) Tukhm e katan 10 gm (4) Tukhm e khatmi 10 gm (5) Barg e karnab 10 gm (

Sponsors

State Takmeel uttib College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients complaining of LUTS Clinically diagnosed patients of BPH USG findings (weight less than 60gm and PVR less than 200cc) Male patients willing to give written informed consent

Exclusion criteria

Exclusion criteria: Patients with severe cardiac and pulmonary diseases Patients with hepatic and renal diseases Vesical Calculus Acute retention of urine Neurogenic bladder Abscess and Carcinoma of the prostate USG findings (weight equal or more than 60gm and PVR equal or more than 200cc) Male patients who not willing to give consent Mentally retarded patients

Design outcomes

Primary

MeasureTime frame
Poor stream of urine Hesitancy during micturition Terminal dribbling Feeling of incomplete emptying of urinary bladder Frequency of urine Nocturia Urgency of urineTimepoint: 0, 10th, 20th, 30th and 40th day

Secondary

MeasureTime frame
Digital Rectal Examination (DRE) USG (Abdomenopelvic) including Full Bladder Volume (FBV) and Residual Urine Volume (RUV)Timepoint: 0 and 40th day

Countries

India

Contacts

Public ContactDr Rakhshinda Baig

Department of Ilmul Jarahat State Takmeel uttib College and Hospital

quavinium@gmail.com9455077880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026